Skip to Content

Tema ETF Trust Tema Oncology ETF

CANC
$
Today’s Change
()

Snapshot
*

Inception Date
Aug 15, 2023
Expense Ratio
0.75%
Type
Global Equities
Fund Owner
Tema
Volume (1m avg. daily)
$161,999
AUM
$4,848,018
Associated Index
None
Inverse/Leveraged
No
Passive/Active
Active
Fractionable on Composer
No
Prospectus

Top 10 Holdings

REGN
Regeneron Pharmaceuticals, Inc.
5.36%
MRK
Merck & Co Inc
4.88%
NOVN
Novartis AG - Registered Shares
4.74%
AZN
Astrazeneca plc
4.1%
4568
Daiichi Sankyo Co., Ltd.
3.77%
ILMN
Illumina Inc
3.52%
ARGX
Argen X SE - ADR
3.29%
BMY
Bristol-Myers Squibb Co.
3.14%
BGNE
BeiGene Ltd - ADR
3.05%
INCY
Incyte Corp.
2.87%

What is CANC?

The actively managed Tema Oncology ETF seeks to provide long-term growth by investing in companies operating in the oncology industry. The fund conducts deep and comprehensive research, in an effort to identify those companies that deliver breakthrough solutions at attractive valuations. Example companies include large pharmaceutical firms, diagnostic focused businesses with products used to diagnose cancer (such as liquid biopsies or cancer genomic screening), medical device companies focused on cancer treatment, and healthcare service providers with a specific strategic focus on helping treat and manage cancer.

1M
3M
6M
YTD
1Y
3Y
Max

CANC
Performance Measures**

for the time period Aug 15, 2023 to Dec 4, 2025

Returns

1M Trailing Return: 16.1%

The percent change in the value over the most recent 1-month period.

3M Trailing Return: 30.4%

The percent change in the value over the most recent 3-month period.

Measures of Risk or Volatility

Max Drawdown: -28.0%

The greatest percent loss from peak to trough in value over the time period.

Standard Deviation: 23.1%

The typical amount that daily returns vary from the mean of the returns over the time period, standardized to a period of a year.

Measures of Risk-Adjusted Performance

Sharpe Ratio: 0.82

The annualized arithmetic mean of the daily returns divided by the annualized standard deviation of the daily returns for the selected time period.

Calmar Ratio: 0.63

The annualized return divided by the max drawdown for the selected time period.

ETFs related toCANC

ETFs correlated to CANC include IBB, IWC, FBT

CANC
Tema ETF Trust - Tema Oncology ETF
IBB
BlackRock Institutional Trust Company N.A. - iShares Biotechnology ETF
IWC
BlackRock Institutional Trust Company N.A. - iShares Micro-Cap ETF
FBT
First Trust Exchange-Traded Fund III - First Trust NYSE Arca Biotechnology Index Fund
VXF
Vanguard Group, Inc. - Vanguard Extended Market Index ETF
LABU
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares
FYC
First Trust Exchange-Traded Fund III - First Trust Small Cap Growth AlphaDEX Fund
IWM
BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF
VTWO
Vanguard Group, Inc. - Vanguard Russell 2000 Index ETF
XBI
SPDR Series Trust - SPDR Biotech ETF
SCHA
Schwab Strategic Trust - Schwab U.S. Small-Cap ETF

What is ETF correlation?

Correlation is a measure of the strength of the relationship between two ETFs. It quantifies the degree to which prices of the two ETFs typically move together.

Here, correlation is measured over the past year with the Pearson correlation coefficient (Pearon’s r), which ranges from -1 to 1.

Using ETF correlations in portfolio and strategy construction

ETF correlations can help you create investing strategies and portfolios. Use them to:

  • Build a diversified portfolio from uncorrelated or inversely correlated ETFs with the aim of minimizing portfolio risk.
  • Compare correlated or related ETFs to find one with a lower expense ratio or higher trading volume.
  • Create an investing strategy that hedges an ETF with an uncorrelated or inversely correlated ETF.

FAQ

CANC is a Global Equities ETF. The actively managed Tema Oncology ETF seeks to provide long-term growth by investing in companies operating in the oncology industry. The fund conducts deep and comprehensive research, in an effort to identify those companies that deliver breakthrough solutions at attractive valuations. Example companies include large pharmaceutical firms, diagnostic focused businesses with products used to diagnose cancer (such as liquid biopsies or cancer genomic screening), medical device companies focused on cancer treatment, and healthcare service providers with a specific strategic focus on helping treat and manage cancer.

Yes, CANC is actively managed. In an actively managed fund, the fund manager makes decisions about how funds are invested. A passively managed fund typically tries to track or follow a market index.

No, CANC is not passively managed. It is actively managed. A passively managed fund typically tries to track or follow a market index. In an actively managed fund, the fund manager makes decisions about how funds are invested.

The 1-month return on CANC is -0.0659%. This is the percent change in the value of CANC over the most recent 1-month period. The 3-month return on CANC is %. This is the percent change in the value of CANC over the most recent 3-month period.

ETFs similar to CANC include IXJ, SMH, and URA.

ETFs correlated to CANC include IBB, IWC, and FBT.

ETFs that are inversely correlated to CANC include LABD, TZA, and RWM.

Disclaimers

*

We show information directly obtained from our data provider, Xignite. Data shown here is provided by Xignite, an unaffiliated third party. Composer believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate.

**

We show information based on calculations performed by Composer using data from our provider. Information provided here is based on calculations performed by Composer using data sourced from Xignite, an unaffiliated third party. Composer believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.